Russell Chan

Gense Technologies

Gense offers an affordable and portable self-help medical imaging device for in-depth health monitoring and preventive screening at home and clinics. The device targets some of the costliest diseases' early detection and chronic disease management for liver, lungs, kidney and more. Developed as a home-based medical imaging modality to assist telemedicine, the imaging scan can be self-administrable by users without any substantive operative training, powered by cloud-based machine learning algorithms. The award-winning startup is built by a team of 15 PhDs and researchers from Stanford, Cambridge, and Hong Kong. The team is also coordinating over 8 partnerships with professors on clinical trials and engineering. Gense has raised USD 2.5mil from grants and investment to date, and developed capacity to mass manufacture with medical device certification. The startup has also been approached by healthcare distributors from over 20 markets globally, including private hospital network, clinic chains, health insurers, and multinational conglomerates.